COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

THE INTERNATIONAL NEUROTOXIN ASSOCIATION
NEW YORK, NY · EIN 273652965 · Form 990 · FY2024 · NTEE G96 · Voluntary Health Associations · Medium ($1M-$10M) · neurotoxins.org
revenue
$1.7M
expenses
$1.6M
net assets
$360K
employees
0
program ratio
89%
mission · from form 990

The INA is a not-for-profit scientific society dedicated to advancing scientific research, supporting education, fostering understanding about botulinum and other neurotoxins. INA provides a forum for the exchange of information and ideas among scientists, clinicians, allied health and other medical professionals, as well as the general public about the science and therapeutic use of neurotoxins. INA organizes the TOXINS conferences, and other educational activities in support of these goals.

profile · synthesized from sources

The International Neurotoxin Association is a not-for-profit scientific society advancing research and education on botulinum and other neurotoxins. It serves scientists, clinicians, and allied health professionals by organizing the biennial TOXINS conferences and facilitating knowledge exchange on the therapeutic use of neurotoxins. The organization also offers educational initiatives including preceptorships for clinical skill development.

named programs · 2 · from sources

What they call their work

Injector Preceptorship Program
CME-certified, one-on-one preceptorships for clinicians to learn or improve botulinum neurotoxin injection skills in various clinical conditions, including spasticity, movement disorders, headache, and cosmetic use
TOXINS Conference
Biennial international conference featuring plenary sessions, didactic tracks, poster sessions, and workshops on the science and clinical applications of botulinum and other neurotoxins
activities · 4 groups

What they do

  • Scientific Conference & Symposium Management 2 activities
    • Host specialized scientific conferences on neurotoxins and related medical fields
      Organizes targeted conferences such as the Latin American Botulinum Toxin Symposium, the International Headache Congress 2025, and the ISPRM 2026 conference to promote knowledge exchange and professional networking in specific neurotoxin-related disciplines.
    • Organize international TOXINS conferences on neurotoxin research and clinical applications
      Hosts biennial international scientific conferences featuring plenary sessions, didactic tracks, practical workshops with live patient demonstrations, and poster sessions to advance knowledge in basic and clinical applications of neurotoxins. Recent conferences include TOXINS 2026 in Madrid, TOXINS 2024 in Berlin, TOXINS 2022 in New Orleans, TOXINS 2017 with 1,051 attendees, and TOXINS 2015 with 752 participants from multiple countries.
  • Professional Membership and Association Benefits 1 activity
    • Offer free membership with access to conference benefits
      Provides free membership to eligible individuals upon application and Board of Directors review, granting access to reduced registration rates for TOXINS conferences and other member benefits.
  • Academic Research Dissemination 1 activity
    • Publish conference proceedings and abstracts in peer-reviewed journals
      Disseminates scientific output from conferences by publishing abstracts and proceedings in journals such as Toxicon and The Botulinum Journal, with open-access availability for up to six months post-event.
  • Uncategorized 1 activity
    • Provide preceptorship training for clinicians in botulinum neurotoxin applications
      Offers the Injector Preceptorship Initiative and CME-certified training programs for clinicians at all experience levels, including direct observation of patient assessments and injections, focused on clinical uses for spasticity, movement disorders, headache, sialorrhea, hyperhidrosis, cosmetic indications, and overactive bladder.
financials · form 990 · fy2024
revenue
Total revenue$1.68M
Contributions & grants$1.68M100%
Program service revenue$00%
Investment income$410%
Other revenue$0
expenses
Total expenses$1.57M
Program expenses89%
Admin / overhead11%
Fundraising0%
Salaries & benefits$0
Grants paid out$0
Largest expense lineProfessional Fees
balance sheet
Total assets$371K
Cash$15K
Investments$0
Liabilities$11K
Net assets$360K
Liquid reserves0.1 mo
5 years on record · 2020–2024 · YoY revenue +2991719.6%
leadership · form 990 part vii · fy2024

Who runs it

board members · 1
  • CYNTHIA COMELLA MD — PAST PRESIDENT
relationships · 13

Who they work with

  • AMA Government — Directs physicians to the AMA for conversion of EACCME credits into AMA PRA Category 1 Credits™.
  • EACCME Government — Collaborates with EACCME to provide accredited continuing medical education credits to conference attendees.
  • Estrel Berlin Partner — Venue partner for the TOXINS 2024 conference.
  • International Headache Society Partner — Collaborates on advancing global headache care, as reflected in shared mission language around expanding access to trained professionals.
  • Madrid Marriott Auditorium Hotel & Conference Center Partner — Host venue for the TOXINS 2026 conference.
  • TOXINS Conference Organizing Committee Partner — Collaborates with the International Neurotoxin Association to organize the TOXINS international conference series.
  • TOXINS conferences Partner — INA organizes the TOXINS conferences as part of its educational programming.
  • The Botulinum Journal Partner — Partnered to publish conference abstracts from TOXINS 2012.
  • The Botulinum Journal Partner — Published abstracts from the TOXINS 2012 conference.
  • Toxicon Partner — Collaborates with Toxicon journal to publish special issue of conference proceedings from TOXINS 2017.
  • Toxicon Partner — Partner journal for publishing conference abstracts from TOXINS 2026.
  • Toxicon Partner — Partnered to publish conference abstracts in an open-access supplement issue of the journal.
  • Toxicon Journal Partner — Published conference proceedings from TOXINS 2015 meeting
strategies · 4

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Equity-Focused Global Knowledge Dissemination
    methodology: equity-focused global health education
    By designing regionally tailored education initiatives, particularly for Latin America and underserved headache care communities, the organization expands equitable access to neurotoxin expertise because localized training increases relevance, adoption, and workforce capacity in under-resourced settings.
  • Expert-Driven, Inclusive Membership Model
    methodology: expert-driven_membership
    By restricting active membership to doctoral-level contributors while including non-doctoral professionals and industry stakeholders through differentiated participation tiers, the organization sustains a high-caliber professional community because it balances scientific rigor with broad field engagement.
  • Interdisciplinary Scientific Convening
    methodology: interdisciplinary-scientific-conference
    By convening world experts across research and clinical disciplines in neurotoxins, the organization advances scientific understanding and clinical practice because structured exchange integrates basic science with real-world application, including hands-on training and live patient demonstrations.
  • Mentor-Based Clinical Training
    methodology: mentor-based personalized learning
    By enabling personalized, mentor-based learning where clinicians observe real-world patient assessments and procedures, the organization improves clinical competence because trainees gain context-specific expertise through direct observation and geographic or specialty-aligned mentorship.